Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ComASP Cefiderocol 0.008-128

K-Number: K230479 · 2023-05-18

Decision Date2023-05-18
Product CodeJWY
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

ComASP Cefiderocol 0.008-128 is a medical device manufactured by Liofilchem s.r.l.. It received FDA 510(k) clearance on 2023-05-18 under approval number K230479. The device is classified under product code JWY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ComASP Cefiderocol 0.008-128?

ComASP Cefiderocol 0.008-128 is a medical device that received FDA 510(k) clearance on 2023-05-18. It is manufactured by Liofilchem s.r.l.. The 510(k) number is K230479.

When was ComASP Cefiderocol 0.008-128 approved by the FDA?

ComASP Cefiderocol 0.008-128 received FDA 510(k) clearance on 2023-05-18, under approval number K230479.

What company makes ComASP Cefiderocol 0.008-128?

ComASP Cefiderocol 0.008-128 is manufactured by Liofilchem s.r.l..

What is the FDA product code for ComASP Cefiderocol 0.008-128?

The FDA product code for ComASP Cefiderocol 0.008-128 is JWY.

Other Devices by Liofilchem s.r.l.

View all 35 devices →

Related Devices (Code: JWY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.